Saturday 17 October 2026
Export CLMT’s income statement to Excel — free account
Calumet, Inc.
CLMT Basic Materials Specialty Chemicals
Calumet, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.1 billion, down 1.25% from fiscal 2024. In the quarter to June 2026, revenue grew 40.8%, EPS grew 35.9%, free cash flow grew 450.7% and total debt fell 1.98%, each against the same quarter a year earlier. Dividend growth for five consecutive years.
57.75
0.49
−0.84%
Follow CLMT
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 |
+8 more quarters Free account |
P/S ratio |
0.69 | 0.75 | 0.42 | 0.39 | |
P/FCF ratio |
42.92 | 761.74 | 30.46 | 0.00 | |
P/Operating CF |
34.18 | (36.23) | 14.80 | 67.49 | |
P/B ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
1.25 | 1.34 | 0.95 | 0.95 | |
EV/EBITDA |
42.90 | 74.08 | 19.30 | 13.25 | |
EV/Operating CF |
39.32 | 107.56 | 36.01 | (349.72) | |
EV/FCF |
78.15 | 1,364.20 | 69.29 | (50.89) | |
Quick Ratio |
0.47 | 0.56 | 0.52 | 0.58 | |
Current Ratio |
0.84 | 0.96 | 1.02 | 1.13 | |
Net Debt/EBITDA |
488.52 | (19.03) | (34.07) | 7.00 | |
Debt/Assets |
97.72% | 96.14% | 89.36% | 89.09% | |
Debt/Equity |
(2.41) | (2.54) | (3.28) | (3.50) | |
Asset Turnover |
1.65 | 1.50 | 1.52 | 1.51 | |
Operating CF/Net income |
(0.96) | 0.27 | (3.12) | 0.08 | |
Capex/Depreciation |
(0.85) | (0.32) | (0.07) | 0.00 | |
Interest Coverage |
(0.77) | (3.35) | (1.27) | 6.02 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
3.66% | 7.60% | 4.98% | 3.92% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.06 | 0.00 | |
Share Based Compensation of Revenue |
0.52% | 3.63% | (0.43%) | 0.00% | |
Graham Net Nets |
(0.92) | (0.92) | (1.49) | (1.61) | |
Graham Number |
21.28 | 24.14 | 8.61 | 8.80 | |
Earnings Yield |
(4.30%) | (6.02%) | (1.96%) | (2.36%) | |
Free Cash Flow Yield |
2.33% | 0.13% | 3.28% | (4.77%) | |
Revenue per Share |
16.50 | 11.84 | 11.97 | 12.40 | |
Operating CF per Share |
1.05 | (0.99) | 1.34 | 0.27 | |
Capex per Share |
(0.44) | (0.15) | (0.15) | (0.10) | |
Free Cash Flow per Share |
0.62 | (1.14) | 1.20 | 0.17 | |
Cash per Share |
1.71 | 2.05 | 2.36 | 2.01 | |
Shareholders Equity per Share |
(12.98) | (11.99) | (8.44) | (8.00) | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
(12.98) | (11.99) | (8.44) | (8.00) | |
Free Cash Flow |
54.00 | (99.40) | 103.80 | 15.10 | |
Working Capital |
(194.00) | (35.20) | 17.10 | 103.80 | |
Capital Expenditures |
(38.30) | (13.20) | (12.70) | (8.40) | |
Net Current Asset Value |
(2,917.10) | (2,870.30) | (2,563.80) | (2,549.10) | |
EV/EBIT |
121.95 | 0.00 | 36.08 | 19.64 | |
Capex to Sales |
0.03 | 0.01 | 0.01 | 0.01 | |
Price to Operating Income |
66.98 | 0.00 | 15.86 | 8.10 | |
| Other line items | |||||
Average Receivables |
361.45 | 330.80 | 255.30 | 292.15 | |
Average Payables |
325.70 | 329.70 | 301.15 | 310.15 | |
Average Inventory |
395.75 | 379.45 | 400.75 | 404.80 | |
Average Assets |
2,789.60 | 2,789.30 | 2,723.55 | 2,687.00 | |
Average Common Equity |
(1,073.40) | (952.75) | (722.30) | (683.75) |
Columns are period end dates